Literature DB >> 35880511

Is Longer Duration or Higher Dose of Steroid Use Effective in Critical COVID-19 Patients?: An Area of Uncertainty.

Won Suk Choi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35880511      PMCID： PMC9313980          DOI： 10.3346/jkms.2022.37.e242

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN： 1011-8934            Impact factor:   5.354


× No keyword cloud information.
  2 in total

1.  High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial.

Authors:  Luis Patricio Maskin; Ignacio Bonelli; Gabriel Leonardo Olarte; Fernando Palizas; Agostina E Velo; María Fernanda Lurbet; Pablo Lovazzano; Sophia Kotsias; Shiry Attie; Ignacio Lopez Saubidet; Natalio D Baredes; Mariano Setten; Pablo Oscar Rodriguez
Journal:  J Intensive Care Med       Date:  2021-12-13       Impact factor: 3.510

2.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.